Cited by 767Menstrual Health and DisordersOvarian function and disordersMenopause: Health Impacts and Treatments

Differential behavioral effects of gonadal steroids in women with and in those without premenstrual syndrome

Open access
Schmidt, Peter J., Nieman, Lynnette K., Danaceau, Merry A., Adams, Linda F., Rubinow, David R.·1998·New England Journal of Medicine

Abstract

BACKGROUND: The symptoms of women with premenstrual syndrome improve in response to suppression of ovarian function, although these women have no evidence of ovarian dysfunction. We undertook a study to determine the role of estrogen and progesterone in this syndrome. METHODS: We first studied the effect of ovarian suppression with leuprolide, an agonist analogue of gonadotropin-releasing hormone, or placebo on symptoms in 20 women with the premenstrual syndrome. Ten women whose symptoms improved during leuprolide treatment were given estradiol and progesterone in a double-blind, crossover design, each for four weeks, during continued leuprolide administration. Women without premenstrual syndrome (normal women) participated in a similar protocol. Outcomes were assessed on the basis of daily self-reports by the patients and biweekly rater-administered symptom-rating scales. RESULTS: The 10 women with premenstrual syndrome who were given leuprolide had a significant decrease in symptoms as compared with base-line values and with values for the 10 women who were given placebo. The 10 women with premenstrual syndrome who were given leuprolide plus estradiol or progesterone had a significant recurrence of symptoms, but no changes in mood occurred in 15 normal women who received the same regimen or in 5 women with premenstrual syndrome who were given placebo hormone during continued leuprolide administration. CONCLUSIONS: In women with premenstrual syndrome, the occurrence of symptoms represents an abnormal response to normal hormonal changes.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1056/nejm199801223380401

Cites

28 of 28 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Prior evidence suggests that individual differences in responsiveness to cycle shifts could be larger in magnitude compared to cycle shifts themselves.

    “Prior evidence suggests another possibility, namely that individual differences in responsiveness to cycle shifts could be larger in magnitude compared to cycle shifts themselves [37].”

    From Menstrual cycle effects on cognitive performance: A meta-analysis (2025) · cites this paper as [37]

    Figure 2 and Table 2 (Discussion; page unavailable) show that women with premenstrual syndrome had increased symptoms after hormone replacement, whereas women without the syndrome did not. That supports differences in responsiveness to hormonal changes, but the paper does not compare the magnitude of those differences with the magnitude of cycle shifts themselves. (LLM, conf=0.84)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 6

  1. [2]2. Muse KN, Cetel NS, Futterman LA, Yen SSC. The premenstrual syn- drome: effects of "medical ovariectomy." N Engl J Med 1984;311:1345- 9.
  2. [6]6. Spitzer RL, Williams JBW, Gibbon M, First MB. Structured clinical in- terview for DSM-III-R -patient edition (SCID, version 1.0). Washing- ton, D.C.: American Psychiatric Press, 1990.
  3. [10]10. Endicott J, Halbreich U. Retrospective report of premenstrual depres- sive changes: factors affecting confirmation by daily ratings. Psychopharma- col Bull 1982;18(3):109-12.
  4. [17]17. Abraham GE, Swerdloff R, Tulchinsky D, Odell WD. Radioimmunoas- say of plasma progesterone. J Clin Endocrinol Metab 1971;32:619-24.
  5. [18]18. Jiang NS, Ryan RJ. Radioimmunoassay for estrogens: a preliminary communication. Mayo Clin Proc 1969;44:461-5.
  6. [25]25. Sarno AP Jr, Miller EJ Jr, Lundblad EG. Premenstrual syndrome: ben- eficial effects of periodic, low-dose danazol. Obstet Gynecol 1987;70:33-6.

Cited by

Sorted by citations

Authors
Schmidt, P. J., Nieman, L. K., Danaceau, M. A., Adams, L. F., & Rubinow, D. R.
Affiliations
  • National Institutes of Health (US)
  • Eunice Kennedy Shriver National Institute of Child Health and Human Development (US)
  • National Institute of Mental Health (US)
Venue
New England Journal of Medicine
Published
1998-01-22
Volume
338
Issue
4
Pages
209-216
ISSN
  • 0028-4793 (ISSN-L)
  • 1533-4406
OpenAlex
W2046110224
Cited by
765
References
28
Citations by year
2026: 30 · 2025: 38 · 2024: 26 · 2023: 27 · 2022: 31 · 2021: 28 · 2020: 21 · 2019: 24 · 2018: 24 · 2017: 26 · 2016: 32 · 2015: 23 · 2014: 24 · 2013: 31 · 2012: 31
FWCI
29.44
Type
journal article
Language
en
Open access
Locations
  • New England Journal of Medicine (publishedVersion)
  • PubMed (publishedVersion)
Funders
Upsher-Smith
Topics
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Menstrual Health and Disorders
  • Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Menopause: Health Impacts and Treatments
Keywords
premenstrual syndrome, premenstrual dysphoric disorder, leuprolide, GnRH agonist, ovarian suppression, estradiol, progesterone, estrogen, symptom recurrence
MeSH terms
Adult, Double-Blind Method, Emotions, Estradiol, Female, Humans, Gonadotropin-Releasing Hormone, Middle Aged, Premenstrual Syndrome, Progesterone, Leuprolide, Cross-Over Studies, Hot Flashes

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review